🇺🇸 FDA
Patent

US 11197884

Modulation of the notch signaling pathway for treatment of respiratory disorders

granted A61KA61K31/7088A61K31/7115

Quick answer

US patent 11197884 (Modulation of the notch signaling pathway for treatment of respiratory disorders) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/7088, A61K31/7115, A61K45/06, A61K9/0019